Isofol Medical Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 4

Employees

  • Stock Symbol
  • ISOFOL

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.07
  • (As of Friday Closing)

Isofol Medical General Information

Description

Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Hospitals/Inpatient Services
Other Healthcare Services
Stock Exchange
STO
Corporate Office
  • Biotech Center
  • Arvid Wallgrens Backe 20
  • 413 46 Gothenburg
  • Sweden
+46 031-797 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Isofol Medical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.07 $0.07 $0.04 - $0.12 $10.7M 162M 586K -$0.02

Isofol Medical Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV (1,555) (1,395) (3,108) 125,604
Revenue 0 68 1,261 2,609
EBITDA (2,938) (3,914) (15,759) (23,113)
Net Income (2,938) (3,488) (15,751) (23,318)
Total Assets 12,334 14,068 20,120 44,350
Total Debt 0 0 183
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Isofol Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Isofol Medical‘s full profile, request access.

Request a free trial

Isofol Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candid
Biotechnology
Gothenburg, Sweden
4 As of 2024
000.00
00000 0000-00-00
00000000 000.00

00000

sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad m
0000 000000000
Stockholm, Sweden
0 As of 0000
000.00
0000 0000-00-00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Isofol Medical Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Modus Therapeutics Formerly VC-backed Stockholm, Sweden 0 000.00 00000000 000.00
You’re viewing 1 of 1 competitors. Get the full list »

Isofol Medical Patents

Isofol Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230095428-A1 [6r]-mthf in 5-fu based chemotherapy of braf- or kras-mutated colorectal cancer Inactive 28-Sep-2021 000000000 0
US-20230097085-A1 [6r]-mthf in 5-fu based chemotherapy of right-sided colorectal cancer Inactive 28-Sep-2021 0000000000 0
US-20230102483-A1 [6r]-mthf in 5-fu based chemotherapy of left-sided colorectal cancer Pending 27-Sep-2021 00000000000
US-20190212341-A1 Methods for treating colorectal and metastatic colorectal cancers Inactive 03-Apr-2018 0000000000
US-20230116137-A1 Methods for treating colorectal and metastatic colorectal cancers Pending 03-Apr-2018 A61K31/519
To view Isofol Medical’s complete patent history, request access »

Isofol Medical Executive Team (13)

Name Title Board Seat Contact Info
Petter Lindqvist Chief Executive Officer
Bengt Gustavsson Founder & Senior Advisor
Magnus Hurst Chief Financial Officer, Finance
You’re viewing 3 of 13 executive team members. Get the full list »

Isofol Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Isofol Medical Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Dermafol 01-Jan-2010 00000 0000 Drug Discovery
To view Isofol Medical’s complete investments history, request access »

Isofol Medical ESG

Risk Overview

Risk Rating

Updated April, 24, 2024

34.08 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,421

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 928

Rank

00.00

Percentile

Pharmaceuticals

Subindustry

00 of 456

Rank

00.0

Percentile

To view Isofol Medical’s complete esg history, request access »

Isofol Medical FAQs

  • When was Isofol Medical founded?

    Isofol Medical was founded in 2008.

  • Who is the founder of Isofol Medical?

    Bengt Gustavsson is the founder of Isofol Medical.

  • Who is the CEO of Isofol Medical?

    Petter Lindqvist is the CEO of Isofol Medical.

  • Where is Isofol Medical headquartered?

    Isofol Medical is headquartered in Gothenburg, Sweden.

  • What is the size of Isofol Medical?

    Isofol Medical has 4 total employees.

  • What industry is Isofol Medical in?

    Isofol Medical’s primary industry is Biotechnology.

  • Is Isofol Medical a private or public company?

    Isofol Medical is a Public company.

  • What is Isofol Medical’s stock symbol?

    The ticker symbol for Isofol Medical is ISOFOL.

  • What is the current stock price of Isofol Medical?

    As of 24-May-2024 the stock price of Isofol Medical is $0.07.

  • What is the current market cap of Isofol Medical?

    The current market capitalization of Isofol Medical is $10.7M.

  • Who are Isofol Medical’s competitors?

    Modus Therapeutics is a competitor of Isofol Medical.

  • What is Isofol Medical’s annual earnings per share (EPS)?

    Isofol Medical’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »